
Biocon Ltd. share price
NSE: BIOCON · Healthcare
₹362.20 -0.51%
Closing price data, updated 17 Nov 2026. 52-week range: -19.0% from high, +13.8% above low.
Price₹362.20
Market cap₹58,918 Cr
P/E130.3
P/B1.69
ROE1.4%
ROCE2.9%
Debt / equity0.45
Dividend yield0.00%
EPS₹2.78
Book value₹214.20
Operating margin10.3%
Dipscan score27 / 100
Share: WhatsAppX / TwitterTelegram
Biocon Ltd. shareholding pattern
As of Sep 2026: Promoters 44.68%, FIIs 8.64%, DIIs 29.30%, Government 0.00%, Public 10.19%, Others 7.19%.
| Holder | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 |
|---|---|---|---|---|---|---|
| Promoters | 44.68% | 44.68% | 44.91% | 54.45% | 54.45% | 54.45% |
| FIIs | 8.64% | 8.14% | 7.52% | 7.39% | 6.61% | 6.04% |
| DIIs | 29.30% | 23.38% | 24.07% | 21.71% | 22.10% | 22.82% |
| Government | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public | 10.19% | 10.26% | 10.01% | 12.38% | 12.71% | 12.58% |
| Others | 7.19% | 13.54% | 13.49% | 4.06% | 4.12% | 4.10% |
| No. of Shareholders | 393,051 | 392,509 | 386,593 | 394,279 | 413,191 | 430,217 |
As filed by the company with the exchanges.
Returns
| 1 day | 1 week | 1 month | 3 months | 6 months | 1 year |
|---|---|---|---|---|---|
| -0.51% | -0.79% | +3.31% | -13.76% | -13.56% | -5.95% |
Growth
| Sales growth, 3 years | +15.3% |
| Sales growth, 5 years | – |
| Profit growth, 3 years | -5.9% |
| Profit growth, 5 years | – |
| Latest quarter sales vs last year | +1.9% |
| Latest quarter profit vs last year | -51.1% |
Strengths and weaknesses
Weaknesses
- Company has low interest coverage ratio.
- Company has a low return on equity of 3.51% over last 3 years.
- Company might be capitalizing the interest cost
- Dividend payout has been low at 10.9% of profits over last 3 years
- Promoter holding has decreased over last 3 years: -16.0%
Peers in Healthcare
| Company | Price | Market cap | P/E | ROE | 1 year |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | ₹1,867.50 | ₹4,48,076 Cr | 40.9 | 14.7% | +8.8% |
| Divi's Laboratories Ltd. | ₹11,080.00 | ₹2,94,139 Cr | 87.5 | 16.2% | +69.4% |
| Torrent Pharmaceuticals Ltd. | ₹4,691.20 | ₹1,78,438 Cr | 84.0 | 27.1% | +22.6% |
| Apollo Hospitals Enterprise Lt | ₹8,771.00 | ₹1,26,114 Cr | 56.2 | 21.9% | +16.9% |
| Laurus Labs Ltd. | ₹2,220.00 | ₹1,19,949 Cr | 89.5 | 18.2% | +125.2% |
| Zydus Lifesciences Ltd. | ₹1,192.00 | ₹1,18,902 Cr | 28.4 | 19.7% | +27.0% |
| Dr. Reddy's Laboratories Ltd. | ₹1,377.90 | ₹1,14,778 Cr | 41.0 | 12.1% | +13.7% |
| Cipla Ltd. | ₹1,394.50 | ₹1,12,658 Cr | 38.9 | 11.8% | -8.0% |
Frequently asked questions
What is the share price of Biocon Ltd.?
Biocon Ltd. (BIOCON) last closed at ₹362.20 (-0.51% on the day).
What is the market cap of Biocon Ltd.?
About ₹58,918 Cr.
What is the P/E ratio of Biocon Ltd.?
The price-to-earnings ratio is 130.3, and return on equity is 1.4%.
Figures are calculated from company results and exchange prices and are for information only.